HWM
ABBV icon

Hemington Wealth Management’s AbbVie ABBV Stock Holding History

Hemington Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$705K Buy
3,048
+194
+7% +$39.5K 0.09% 68
2025
Q2 		$529K Buy
2,854
+136
+5% +$25.3K 0.08% 76
2025
Q1 		$569K Buy
2,718
+182
+7% +$35.4K 0.09% 69
2024
Q4 		$450K Buy
2,536
+150
+6% +$27.6K 0.11% 79
2024
Q3 		$486K Sell
2,386
-105
-4% -$19.6K 0.13% 71
2024
Q2 		$427K Buy
2,491
+105
+4% +$17.4K 0.14% 78
2024
Q1 		$435K Sell
2,386
-82
-3% -$14.1K 0.16% 79
2023
Q4 		$382K Buy
2,468
+220
+10% +$32.1K 0.15% 78
2023
Q3 		$335K Sell
2,248
-200
-8% -$29.4K 0.16% 71
2023
Q2 		$329K Sell
2,448
-110
-4% -$16.1K 0.13% 74
2023
Q1 		$407K Buy
2,558
+37
+1% +$5.66K 0.16% 66
2022
Q4 		$407K Buy
2,521
+99
+4% +$15.2K 0.17% 62
2022
Q3 		$325K Sell
2,422
-6
-0.2% -$861 0.14% 66
2022
Q2 		$372K Buy
2,428
+44
+2% +$6.72K 0.15% 69
2022
Q1 		$387K Buy
+2,384
New +$346K 0.13% 76
2021
Q4 		– Sell
-1,902
Closed -$205K – 82
2021
Q3 		$205K Buy
1,902
+38
+2% +$4.34K 0.08% 95
2021
Q2 		$210K Buy
+1,864
New +$210K 0.09% 86

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hemington Wealth Management's ABBV Position: Q3 2025 in Review

Hemington Wealth Management increased its AbbVie (ABBV) stake by 6.8% in Q3 2025, buying an estimated $39.5K and bringing the position to 3,048 shares worth $705K. The position accounts for 0.09% of the portfolio, ranked #68.

Hemington Wealth Management first reported a position in ABBV in Q2 2021 and has held it in 17 quarters since. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Hemington Wealth Management held 3,048 shares of AbbVie worth $705K as of Q3 2025.
  • Hemington Wealth Management bought 194 AbbVie shares in Q3 2025, an estimated $39.5K.
  • AbbVie made up 0.09% of Hemington Wealth Management's portfolio in Q3 2025, its #68 holding.
  • Hemington Wealth Management first reported a position in AbbVie in Q2 2021 and has held it in 17 quarters since.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Hemington Wealth Management's 13F filing for Q3 2025, filed 24 Oct 2025.